Our Company
About Us
Our Team
Board of Directors
Scientific Advisory Board
Contact Us
Our Strategy
Scientific Platform
Therapeutic Areas
Manufacturing
Research & Development
Pipeline
Clinical Trials
Posters & Publications
Patients & Families
Investors & Media
Overview
News Releases
Events & Presentations
Stock Information
Corporate Governance
Financial Information
Investor Resources
Join Our Team
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson’s disease: an open label, phase I trial.